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Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, Bethesda MD, USANematodes can be free-living or parasitic in nature. Infections with
parasitic nematodes that directly or indirectly affect the health and pro-
ductivity of humans and livestock have been the subject of scientiﬁc
studies for decades. Overall, the treatment and control of nematode par-
asites are limited and dependent on single or repeated administration of
anthelmintics, a strategy that has led to true anthelmintic resistance in
animals and the concern for resistance inmass drug administration pro-
grams for humans. Efforts to discover new agents that offer improved
performance in efﬁcacy, safety and convenience are complicated with
many challenges (Geary et al., 2015). An alternative strategy to worm
control has been vaccination, where the concept of targeting intestinal
proteins as ‘hidden antigens’ (Munn, 1997) has been explored for sever-
al helminth parasites with mixed results (Bassetto et al., 2011; Morris
et al., 2013; Pearson et al., 2010). Global ‘omic’ approaches are now
paving the way to better understand the biology of many organisms
and to help identify and/or infer functional attributes of various genes
and proteins (Rosa et al., 2015; Taylor et al., 2013) that might identify
“soft spots” in the organism(s) that in turn greatly narrows the large
numbers of targets that could be exploited for therapeutic or prophylac-
tic approaches.
In this issue of Ebiomedicine, Wang et al. (2015) describe the
establishment of a comprehensive functional database for nematode in-
testinal proteins. Using transcriptional and proteomic complements of
representative nematodes, a selection of protein families that are
universal or restricted to intestinal regions (IntFams) forms the
basis of the study. While Haemonchus contortus, Ascaris suum and
Trichuris suis are used as surrogates for similar niche speciﬁc human-
gastrointestinal infections of Necator americanus, Ascaris lumbricoides
and Trichuris trichiura, inferences for clade-speciﬁc representative para-
sitic ﬁlarial nematodes (Brugia malayi and Loa loa) have also been de-
rived. The study is centered on the identiﬁcation of conserved IntFams
(cIntFams) across all nematodes that have the potential for broad-
spectrum pan-nematoda control, while species or clade-speciﬁc diver-
gent IntFams (ncIntfams) represent novel functions. There are a number
of reasons that make this study interesting. Firstly, this knowledgebase
provides a launchpad not only for directed research to understand in-
herent biological functions and pathways, but also as a gateway for
the rapid identiﬁcation of potential therapeutic targets. Secondly, if we
consider the time and effort required for traditional drug screening in
experimentally-infected animals or in-vitro screens, fusion of molecular
techniques with evolutionary informatics presents a fertile ground forDOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.07.030.
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principle, Wang, Q. et al., describe the identiﬁcation of IntFam proteins
that are homologous to host proteins but are sufﬁciently different
to allow for distinct ligand binding, a concept that, certainly warrants
further drug-targeting studies. Further, not all parasitic nematodes
can be maintained in-vitro or in animal models, and hence there is
limited availability of biological material available to the scientiﬁc
community. Though drawing parallels from the database can be very
helpful in such cases, one needs to be cautious extrapolating across an
entire phylum given the variability among the nematode genomes. Un-
derstanding the functional implications of these species speciﬁc IntFams
would enable selective strategies to target intestinal parasitic nema-
todes, ﬁlarial parasites, and other veterinary important nematode
parasites.
From the therapeutic viewpoint, the best and quick way to address
the hurdles of controlling parasitic nematodes lies in the solid under-
standing of the basic biology of the organism and drawing parallels to
targets of approved drugs that already have established safety proﬁles.
This approach of repurposing FDA approved drugs (O'Connell et al.,
2015) greatly cuts down the huge lag-time in identifying lead-
compound(s) for testing and is gainingmomentum in the global efforts
to control helminth infections. This study byWang et al., hopefully will
be a beneﬁcial tool for narrowing down such targetable pan-nematoda
or tissue-speciﬁc or species speciﬁc ‘spot spots’ that can possibly
address potential problems of drug resistance as well.Conﬂict of Interest
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